These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12556551)

  • 1. Antiretroviral therapy during pregnancy and the risk of an adverse outcome.
    Thorne C; Fiore S; Rudin C
    N Engl J Med; 2003 Jan; 348(5):471-2; author reply 471-2. PubMed ID: 12556551
    [No Abstract]   [Full Text] [Related]  

  • 2. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
    Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
    Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premature labour precipitated by highly active antiretroviral therapy: an adverse reaction in a newly diagnosed HIV-positive patient.
    Broom J; Sowden D
    Sex Health; 2011 Sep; 8(3):436-8. PubMed ID: 21851788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women.
    Grosch-Woerner I; Puch K; Maier RF; Niehues T; Notheis G; Patel D; Casteleyn S; Feiterna-Sperling C; Groeger S; Zaknun D;
    HIV Med; 2008 Jan; 9(1):6-13. PubMed ID: 18199167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [German-Austrian guidelines for HIV therapy during pregnancy (May, 2001, update].
    Buchholz B; ;
    Dtsch Med Wochenschr; 2003 May; 128 Suppl 1():S19-31. PubMed ID: 12736864
    [No Abstract]   [Full Text] [Related]  

  • 6. Side effects and complications. Risk of deformities very low in infants exposed to HAART.
    TreatmentUpdate; 2009 Feb; 21(2):8-9. PubMed ID: 19391265
    [No Abstract]   [Full Text] [Related]  

  • 7. The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is 'the more the merrier'?
    Martin F; Taylor GP
    J Antimicrob Chemother; 2009 Nov; 64(5):895-900. PubMed ID: 19706669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral drug use during pregnancy and risk of premature delivery: is there a connection?
    Kourtis AP
    J Infect Dis; 2010 Apr; 201(7):978-80. PubMed ID: 20196653
    [No Abstract]   [Full Text] [Related]  

  • 9. Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy.
    Haeri S; Shauer M; Dale M; Leslie J; Baker AM; Saddlemire S; Boggess K
    Am J Obstet Gynecol; 2009 Sep; 201(3):315.e1-5. PubMed ID: 19733286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral therapy during pregnancy and the risk of an adverse outcome.
    Tuomala RE; Shapiro DE; Mofenson LM; Bryson Y; Culnane M; Hughes MD; O'Sullivan MJ; Scott G; Stek AM; Wara D; Bulterys M
    N Engl J Med; 2002 Jun; 346(24):1863-70. PubMed ID: 12063370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to Kourtis et al. 'Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis'.
    Townsend CL; Cortina-Borja M; Peckham CS; Tookey PA
    AIDS; 2007 Aug; 21(13):1831-2. PubMed ID: 17690590
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis.
    Kourtis AP; Schmid CH; Jamieson DJ; Lau J
    AIDS; 2007 Mar; 21(5):607-15. PubMed ID: 17314523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of gender and pregnancy on antiretroviral therapy for HIV: pharmacokinetic and disease-related differences.
    Scarsi KK; Postelnick MJ
    J Gend Specif Med; 2003; 6(1):7-16. PubMed ID: 12661172
    [No Abstract]   [Full Text] [Related]  

  • 14. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth.
    Szyld EG; Warley EM; Freimanis L; Gonin R; Cahn PE; Calvet GA; Duarte G; Melo VH; Read JS;
    AIDS; 2006 Nov; 20(18):2345-53. PubMed ID: 17117021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral basics.
    Miller N
    Midwifery Today Int Midwife; 2005; (73):30-4. PubMed ID: 15835846
    [No Abstract]   [Full Text] [Related]  

  • 16. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
    Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
    Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updated recommendations for reducing vertical HIV transmission.
    Paul SM; Burr CK; DiFerdinando GT
    N J Med; 2001 Sep; 98(9):35-8. PubMed ID: 11586883
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased rates of preterm delivery are associated with the initiation of highly active antiretrovial therapy during pregnancy: a single-center cohort study.
    Martin F; Taylor GP
    J Infect Dis; 2007 Aug; 196(4):558-61. PubMed ID: 17624841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side effects and complications. HAART and the safety of the fetus.
    TreatmentUpdate; 2009 Feb; 21(2):6-7. PubMed ID: 19391263
    [No Abstract]   [Full Text] [Related]  

  • 20. Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003.
    Martí C; Peña JM; Bates I; Madero R; de José I; Pallardo LF; Arribas JR; Gonzalez-Garcia J; Gonzalez A; Vazquez JJ
    Acta Obstet Gynecol Scand; 2007; 86(4):409-15. PubMed ID: 17486461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.